On April 2020, Dr. Reddys Laboratories Limited announced the launch of Generic Dasatinib with the name of Invista® brand in India.
This drug is equivalent of the Innovator brand. It is to be used in India for the treatment of chronic myeloid leukemia (CML).
CML is a type of blood-cell cancer that begins in the bone marrow.
The development and launch of Invista® (generic dasatinib) is an important step to improve access to medicines at affordable prices for CML patients in India.
Dr. Reddy’s Invista® is available in 50, 70 and 100 mg tablets in India.
Dasatinib price in India is very low as compared to the International market.
Contact me for any questions related to generic Dasatinib. I would be happy to help. You can contact me directly on WhatsApp by simply click this link https//wa.me/+918851226314 , WeChat: DEV-53 or send me an e-mail dev@generichope.com